HST Global Inc
HST Global, Inc. operates in the healthcare, software and media, and transportation industries. It offers Qwyit, a cryptographic protocol. HST Global, Inc. is based in Virginia Beach, Virginia.
HST Global Inc (HSTC) - Net Assets
Latest net assets as of September 2025: $5.58 Million USD
Based on the latest financial reports, HST Global Inc (HSTC) has net assets worth $5.58 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.19 Million) and total liabilities ($610.98K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.58 Million |
| % of Total Assets | 90.13% |
| Annual Growth Rate | 4.28% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 230.21 |
HST Global Inc - Net Assets Trend (1986–2025)
This chart illustrates how HST Global Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for HST Global Inc (1986–2025)
The table below shows the annual net assets of HST Global Inc from 1986 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $12.31 Million | +2179.88% |
| 2023-12-31 | $-592.07K | -32.79% |
| 2022-12-31 | $-445.86K | -48.23% |
| 2021-12-31 | $-300.78K | -97.33% |
| 2020-12-31 | $-152.42K | -4343.82% |
| 2019-12-31 | $-3.43K | +99.90% |
| 2018-12-31 | $-3.37 Million | -5.59% |
| 2017-12-31 | $-3.19 Million | -5.45% |
| 2016-12-31 | $-3.03 Million | -6.06% |
| 2015-12-31 | $-2.85 Million | -7.36% |
| 2014-12-31 | $-2.66 Million | -7.47% |
| 2013-12-31 | $-2.47 Million | -8.45% |
| 2012-12-31 | $-2.28 Million | -19.73% |
| 2011-12-31 | $-1.91 Million | -3.27% |
| 2010-12-31 | $-1.84 Million | -38.92% |
| 2009-12-31 | $-1.33 Million | -232.31% |
| 2008-12-31 | $-399.67K | -869.10% |
| 2007-12-31 | $51.97K | -98.01% |
| 2006-12-31 | $2.61 Million | +873.73% |
| 2005-12-31 | $-337.27K | +14.42% |
| 2004-12-31 | $-394.11K | +34.85% |
| 2003-12-31 | $-604.91K | -438.82% |
| 2002-12-31 | $-112.27K | +93.59% |
| 2001-12-31 | $-1.75 Million | -143.44% |
| 2000-12-31 | $-720.00K | -700.00% |
| 1999-12-31 | $-90.00K | -106.67% |
| 1998-12-31 | $1.35 Million | +196.43% |
| 1997-12-31 | $-1.40 Million | -180.00% |
| 1996-12-31 | $-500.00K | -145.45% |
| 1995-12-31 | $1.10 Million | -66.67% |
| 1994-12-31 | $3.30 Million | +37.50% |
| 1993-12-31 | $2.40 Million | -22.58% |
| 1992-12-31 | $3.10 Million | -13.89% |
| 1991-12-31 | $3.60 Million | +16.13% |
| 1990-12-31 | $3.10 Million | -6.06% |
| 1989-12-31 | $3.30 Million | +43.48% |
| 1988-12-31 | $2.30 Million | -8.00% |
| 1987-12-31 | $2.50 Million | +4.17% |
| 1986-12-31 | $2.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to HST Global Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 688787000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $141.11K | 1.15% |
| Other Components | $19.26 Million | 156.41% |
| Total Equity | $12.31 Million | 100.00% |
HST Global Inc Competitors by Market Cap
The table below lists competitors of HST Global Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hyundai HT CoLtd
KQ:039010
|
$27.52 Million |
|
Highest Performances Holdings Inc.
NASDAQ:HPH
|
$27.53 Million |
|
Highland Copper Company Inc
OTCQB:HDRSF
|
$27.54 Million |
|
Brd. Klee A/S
CO:KLEE-B
|
$27.54 Million |
|
WFE Technology Corporation
TWO:6474
|
$27.51 Million |
|
IDIS Holdings Co. Ltd
KQ:054800
|
$27.51 Million |
|
Jinli Group Holdings Ltd
TW:8429
|
$27.50 Million |
|
Nhoa SA
PA:NHOA
|
$27.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HST Global Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2025, total equity changed from -592,067 to 12,314,285, a change of 12,906,352.
- Net loss of 860,695 reduced equity.
- Other factors increased equity by 13,767,047.
Equity Change Factors (2023 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-860.70K | -6.99% |
| Other Changes | $13.77 Million | +111.8% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares HST Global Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.51x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 21.17x to 9.51x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-12-31 | $0.04 | $0.83 | x |
| 1987-12-31 | $0.04 | $0.83 | x |
| 1988-12-31 | $0.04 | $0.83 | x |
| 1989-12-31 | $0.00 | $0.83 | x |
| 1990-12-31 | $0.00 | $0.83 | x |
| 1991-12-31 | $0.00 | $0.83 | x |
| 1992-12-31 | $0.00 | $0.83 | x |
| 1993-12-31 | $0.00 | $0.83 | x |
| 1994-12-31 | $0.00 | $0.83 | x |
| 1995-12-31 | $0.00 | $0.83 | x |
| 1996-12-31 | $0.00 | $0.83 | x |
| 1997-12-31 | $-0.14 | $0.83 | x |
| 1998-12-31 | $134.00 | $0.83 | x |
| 1999-12-31 | $-0.01 | $0.83 | x |
| 2000-12-31 | $-0.07 | $0.83 | x |
| 2001-12-31 | $0.00 | $0.83 | x |
| 2002-12-31 | $0.00 | $0.83 | x |
| 2003-12-31 | $0.00 | $0.83 | x |
| 2004-12-31 | $0.00 | $0.83 | x |
| 2005-12-31 | $-0.01 | $0.83 | x |
| 2006-12-31 | $-0.03 | $0.83 | x |
| 2007-12-31 | $0.00 | $0.83 | x |
| 2008-12-31 | $-0.02 | $0.83 | x |
| 2009-12-31 | $-0.05 | $0.83 | x |
| 2010-12-31 | $-0.06 | $0.83 | x |
| 2011-12-31 | $-0.05 | $0.83 | x |
| 2012-12-31 | $-0.06 | $0.83 | x |
| 2013-12-31 | $-0.07 | $0.83 | x |
| 2014-12-31 | $-0.07 | $0.83 | x |
| 2015-12-31 | $-0.08 | $0.83 | x |
| 2016-12-31 | $-0.08 | $0.83 | x |
| 2017-12-31 | $-0.09 | $0.83 | x |
| 2018-12-31 | $-1.38 | $0.83 | x |
| 2019-12-31 | $0.00 | $0.83 | x |
| 2020-12-31 | $-0.03 | $0.83 | x |
| 2021-12-31 | $-0.06 | $0.83 | x |
| 2022-12-31 | $-0.08 | $0.83 | x |
| 2023-12-31 | $-0.11 | $0.83 | x |
| 2025-12-31 | $0.09 | $0.83 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently HST Global Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -164.26%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 1.06x
- Recent ROE (-6.99%) is below the historical average (-4.05%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | -8.00% | -66.67% | 0.12x | 1.04x | $-450.00K |
| 1987 | -11.54% | -13.04% | 0.70x | 1.27x | $-560.00K |
| 1988 | -8.70% | -4.26% | 1.57x | 1.30x | $-430.00K |
| 1989 | 3.03% | 1.41% | 1.61x | 1.33x | $-230.00K |
| 1990 | -3.23% | -2.38% | 0.98x | 1.39x | $-410.00K |
| 1991 | 5.56% | 3.13% | 1.00x | 1.78x | $-160.00K |
| 1992 | -16.13% | -6.85% | 1.35x | 1.74x | $-810.00K |
| 1993 | -20.83% | -6.58% | 1.04x | 3.04x | $-740.00K |
| 1994 | 18.18% | 4.38% | 1.65x | 2.52x | $270.00K |
| 1995 | -218.18% | -23.53% | 1.50x | 6.18x | $-2.51 Million |
| 1996 | 0.00% | -48.53% | 2.00x | 0.00x | $-3.25 Million |
| 1997 | 0.00% | -3066.67% | 0.01x | 0.00x | $-780.00K |
| 1998 | 108.96% | 811.11% | 0.05x | 2.45x | $1.33 Million |
| 1999 | 0.00% | -116.67% | 2.25x | 0.00x | $-201.00K |
| 2000 | 0.00% | -127.03% | 0.85x | 0.00x | $-1.34 Million |
| 2001 | 0.00% | -124.68% | 28.81x | 0.00x | $-1.30 Million |
| 2002 | 0.00% | -8.16% | 0.89x | 0.00x | $47.82K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $574.33K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-39.28K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.11 Million |
| 2006 | 0.00% | -6.49% | 0.47x | 0.00x | $-571.50K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $90.04K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.47 Million |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.23 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-663.50K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-349.47K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-147.80K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $54.66K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $81.17K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $89.65K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $129.73K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $154.26K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $158.76K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $426.92K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-194.76K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-120.92K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-100.49K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-86.79K |
| 2025 | -6.99% | -164.26% | 0.04x | 1.06x | $-2.09 Million |
Industry Comparison
This section compares HST Global Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HST Global Inc (HSTC) | $5.58 Million | -8.00% | 0.11x | $27.52 Million |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |